Literature DB >> 17056376

25-gauge scleral tunnel transconjunctival vitrectomy.

Hiroyuki Shimada1, Hiroyuki Nakashizuka, Ryuzaburo Mori, Yoshihiro Mizutani, Takayuki Hattori.   

Abstract

PURPOSE: To compare the intraocular fluid leakage rate between 25-gauge (25G) transconjunctival vitrectomy with scleral tunnels and standard 25G transconjunctival vitrectomy.
DESIGN: Single-center, retrospective, interventional case series.
METHODS: Transconjunctival vitrectomies were conducted by the use of only 25G instruments with peripheral vitrectomy. Standard 25G vitrectomy was conducted in 542 eyes and 25G vitrectomy with scleral tunnels in 337 eyes. The scleral tunnel was created by inserting trocars at an oblique angle.
RESULTS: The intraocular fluid leakage rate was significantly lower (Fisher exact probability test: P < .0001) when scleral tunnels were used in 25G vitrectomy (1%, five of 337 eyes) compared with standard 25G vitrectomy (9%, 50 of 542 eyes). The wound leakage rate was significantly lower when using (rather than not) scleral tunnels in 25G vitrectomy, both without air-gas (P = .0258) and with air exchange (P = .0007).
CONCLUSION: The use of scleral tunnels in 25G transconjunctival vitrectomy reduces the frequency of wound leakage even when the peripheral vitreous is removed.

Mesh:

Substances:

Year:  2006        PMID: 17056376     DOI: 10.1016/j.ajo.2006.05.057

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  27 in total

1.  A case of persistent hypotony following 23-gauge vitrectomy.

Authors:  Shinsuke Ataka; Makoto Yamaguchi; Takeya Kohno; Kunihiko Shiraki
Journal:  Int Ophthalmol       Date:  2012-02-14       Impact factor: 2.031

2.  A new infusion sustainer that stabilizes perfusion during sutureless 25-gauge vitrectomy.

Authors:  Takayuki Hattori; Hiroyuki Shimada; Hiroyuki Nakashizuka; Ryusaburo Mori; Yoshihiro Mizutani; Mitsuko Yuzawa
Journal:  Int Ophthalmol       Date:  2010-04-02       Impact factor: 2.031

3.  [Three-dimensional visualization of sclerotomies with ultrasound biomicroscopy. Comparison of 20 and 23 gauge incisions on the porcine eyeball].

Authors:  V Witte; E Berger; R Guthoff; O Stachs
Journal:  Ophthalmologe       Date:  2011-07       Impact factor: 1.059

4.  Influence of sutureless 23-gauge sclerotomy architecture on postoperative intraocular pressure decrease: results of a multivariate analysis.

Authors:  Rachid Tahiri Joutei Hassani; Mohamed El Sanharawi; Raphael Adam; Claire Monin; Sylvère Dupont-Monod; Christophe Baudouin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-10-30       Impact factor: 3.117

5.  Comparative study of 27-gauge and 25-gauge vitrectomy performed as day surgery.

Authors:  Ryusaburo Mori; Saigen Naruse; Hiroyuki Shimada
Journal:  Int Ophthalmol       Date:  2017-07-03       Impact factor: 2.031

Review 6.  25th RCOphth Congress, President's Session paper: 25 years of progress in vitreoretinal surgery.

Authors:  G W Aylward
Journal:  Eye (Lond)       Date:  2014-07-04       Impact factor: 3.775

7.  Comparative outcomes of pars plana vitrectomy in acute postoperative endophthalmitis with 25-gauge and 20-gauge techniques.

Authors:  Tugrul Altan; Ziya Kapran; Ilker Eser; Nur Acar; Yaprak Banu Unver; Serap Yurttaser
Journal:  Jpn J Ophthalmol       Date:  2009-10-22       Impact factor: 2.447

8.  Sutureless 25-gauge vitrectomy for idiopathic macular hole repair.

Authors:  Stanislao Rizzo; Claudia Belting; Federica Cresti; Federica Genovesi-Ebert
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-03-15       Impact factor: 3.117

9.  Comparison of 27-gauge versus 25-gauge vitrectomy results in patients with epiretinal membrane: 6-month follow-up.

Authors:  Wojciech Lubiński; Wojciech Gosławski; Karolina Podborączyńska-Jodko; Maciej Mularczyk; Michał Post
Journal:  Int Ophthalmol       Date:  2020-01-19       Impact factor: 2.031

10.  Surgical outcomes of transconjunctival sutureless 23-gauge vitrectomy with silicone oil injection.

Authors:  Tansu Erakgun; Sait Egrilmez
Journal:  Indian J Ophthalmol       Date:  2009 Mar-Apr       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.